![Aaron Fletcher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 157 858 $ al 31/07/2026
Aaron G.
L.
Fletcher is the founder of Bios Research LLC, founded in 2012, serving as President & Chief Executive Officer.
Dr. Fletcher is the founder of BIOS Capital Management LP, founded in 2014, serving as Managing Partner.
Current jobs include Chairman at Actuate Therapeutics, Inc. since 2015, Director at ONL Therapeutics, Inc. since 2024, Independent Director at Cognition Therapeutics, Inc. since 2015, and Professor at Dallas Baptist University since 2008.
Former jobs include Chairman at TFF Pharmaceuticals, Inc. from 2018 to 2023, Director at Rein Therapeutics, Inc. from 2014 to 2023, Director at Abilitech Medical, Inc. from 2016 to 2023, Independent Director at SWK Holdings Corp.
from 2019 to 2021, Independent Director at Cue Biopharma, Inc. from 2019 to 2023, and Director at Lung Therapeutics LLC from 2014 to 2023.
Education includes a doctorate from Colorado State University conferred in 2007 and an undergraduate degree from York University (Nebraska).
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 21/05/2026 | 77.085 ( 0,32 % ) | 85 564 $ | 31/07/2026 | |
| 17/06/2026 | 81.229 ( 0,09 % ) | 72 294 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| COGNITION THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/07/2015 |
| ACTUATE THERAPEUTICS, INC. | Presidente | 01/04/2015 |
Bios Research LLC
 Bios Research LLC Investment ManagersFinance Provides investment advice | Director Ejecutivo | 01/01/2012 |
BIOS Capital Management LP
 BIOS Capital Management LP Investment ManagersFinance BIOS Partners invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and medical device sectors. It provides financing for early and later stage capital requirements. | Fundador | 01/01/2014 |
Dallas Baptist University
 Dallas Baptist University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2008 |
ONL Therapeutics, Inc.
 ONL Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for the treatment of retinal diseases | Director/Miembro de la Junta | 01/09/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| TFF PHARMACEUTICALS, INC. | Presidente | 21/11/2023 |
| CUE BIOPHARMA, INC. | Director/Miembro de la Junta | 09/10/2023 |
Lung Therapeutics LLC
 Lung Therapeutics LLC BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel pipeline of first-in-class medicines for fibrosis | Director/Miembro de la Junta | 01/10/2023 |
| ░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 14 |
|---|---|
Rein Therapeutics, Inc.
 Rein Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops stapled peptide drugs | Health Technology |
ONL Therapeutics, Inc.
ONL Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for the treatment of retinal diseases | Health Technology |
Lung Therapeutics LLC
Lung Therapeutics LLC BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel pipeline of first-in-class medicines for fibrosis | Health Technology |
Colorado State University
 Colorado State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dallas Baptist University
Dallas Baptist University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cognition Therapeutics, Inc.
 Cognition Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage neuroscience company that develops drugs to help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders | Health Technology |
York College
 York College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SWK Holdings Corp.
 SWK Holdings Corp. Finance/Rental/LeasingFinance Operates as an investment holding company with interest in providing financing and pharmaceutical development solutions | Finance |
Bios Research LLC
Bios Research LLC Investment ManagersFinance Provides investment advice | Finance |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Actuate Therapeutics, Inc.
 Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel therapeutics which target cancers and neurodegenerative diseases | Health Technology |
BIOS Capital Management LP
BIOS Capital Management LP Investment ManagersFinance BIOS Partners invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and medical device sectors. It provides financing for early and later stage capital requirements. | Finance |
TFF Pharmaceuticals, Inc.
 TFF Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures inhaled dry powder drugs for the treatment of pulmonary diseases and conditions | Health Technology |
Abilitech Medical, Inc.
 Abilitech Medical, Inc. Medical/Nursing ServicesHealth Services Providing health care services | Health Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
